Literature DB >> 15659811

Increased mitochondrial and nuclear gene expression of cytochrome oxidase subunits I and IV in neuronal aging.

Patrizia Fattoretti1, Carlo Bertoni-Freddari, Belinda Giorgetti, Marta Balietti.   

Abstract

To assess the role of mitochondrial metabolic competence (MMC) in neuronal aging, quantitative immunohistochemistry of cytochrome oxidase (COX) subunits I (mitochondrial-encoded) and IV (nuclear-encoded) was carried out in the cerebellar cortex of adult and old rats. The optical density (OD) values of the immunostained COX subunits I and IV were measured on an overall area of 75,000 microm(2) in the granular and molecular layers of the cerebellar cortex of each animal. In old animals, OD values of subunit I were increased by 35.5 and 34.2% in the molecular and granular layers, respectively, but only the difference found in the latter cerebellar zone was statistically significant (p < 0.05%). As regards subunit IV, old animals showed higher, not significant, densitometric values in the molecular (120.6%) and granular (126.8%) layers. The present findings sustain that gene expression of COX subunits I and IV appears not to be involved in the well-documented time-related mitochondrial decay. The proper functioning of COX depends on several factors that can affect MMC in the aging cell. In the fully assembled holoenzyme, both the subunits I and IV span the inner mitochondrial membrane. On the basis of these molecular biology data, it is reasonable to suppose that any alteration of the physicochemical features and chemical composition of the mitochondrial membranes reported to occur in aging (e.g., decreased membrane fluidity and cardiolipin content, increased cholesterol/phospholipid molar ratio and free-radical damage, etc.) may significantly affect the proper assembling of the enzyme and, in turn, its activity. Considering the reported significant decline of COX activity with advancing age, our findings further support that an adequate mitochondrial metabolic competence, while including proper nuclear and mitochondrial gene expression of subunits of the respiratory chain, relies on the overall balance among various determinants that can be differently damaged by aging and represent critical causative events responsible for the age-related functional decline of selected mitochondrial populations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15659811     DOI: 10.1196/annals.1329.038

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  5 in total

1.  Mitochondrial Dysfunction during Brain Aging: Role of Oxidative Stress and Modulation by Antioxidant Supplementation.

Authors:  Sasanka Chakrabarti; Soumyabrata Munshi; Kalpita Banerjee; Ishita Guha Thakurta; Maitrayee Sinha; Maria Bindu Bagh
Journal:  Aging Dis       Date:  2011-03-23       Impact factor: 6.745

2.  Proteomic analysis and functional characterization of mouse brain mitochondria during aging reveal alterations in energy metabolism.

Authors:  Kelly L Stauch; Phillip R Purnell; Lance M Villeneuve; Howard S Fox
Journal:  Proteomics       Date:  2015-02-10       Impact factor: 3.984

3.  Discrete molecular states in the brain accompany changing responses to a vocal signal.

Authors:  Shu Dong; Kirstin L Replogle; Linda Hasadsri; Brian S Imai; Peter M Yau; Sandra Rodriguez-Zas; Bruce R Southey; Jonathan V Sweedler; David F Clayton
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-18       Impact factor: 11.205

4.  Low activity and poor membrane tethering for rabbit brain cytochrome C oxidase in cholesterol-copper Alzheimer's model.

Authors:  Neetu Mohan; Trevor Alleyne; Jerome Joseph; Andrew Adogwa
Journal:  J Mol Neurosci       Date:  2009-05-22       Impact factor: 3.444

5.  Physical exercise regulates p53 activity targeting SCO2 and increases mitochondrial COX biogenesis in cardiac muscle with age.

Authors:  Zhengtang Qi; Jie He; Yuhui Su; Qiang He; Jingxia Liu; Lu Yu; Omar Al-Attas; Tajamul Hussain; Shuzhe Ding; Liu Ji; Min Qian
Journal:  PLoS One       Date:  2011-07-07       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.